Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Newer GLP-1 and dual-agonist therapies improved outcomes, but limitations remained
GLP-1 medications are approved for adults who have a body mass index (BMI) of 30 or higher, or a BMI of at least 27 plus a weight-related medical condition, such as the following: Type 2 diabetes High blood pressure High cholesterol Obstructive sleep apnea Cardiovascular disease that increases the risk of heart attack or stroke MASH, or metabolic dysfunctionassociated steatohepatitis, a form of liver inflammation Avlin Imaeda, MD, PhD, a Yale Medicine gastroenterologist who is board-certified in obesity medicine, notes that qualifying for the medication based on heart disease aloneoften necessary for insurance coveragecan be challenging
A lower-dose GLP-1/GIP protocol designed for women who want metabolic benefits energy, focus, sleep, lean body composition without aggressive weight loss
Programs include: Nutritional analysis & consultation Laboratory testing Weekly injections Lifestyle & fitness recommendations Flexible payment options This comprehensive approach not only supports weight loss but also reduces risks of obesity-related conditions, making it a long-term investment in your health.
